FindTrial
Sign In

Role of advanced imaging in breast lumps

Role of DW-MRI in differentiating benign and malignant breast lesions. - DW-MRI

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/08/015241
Enrollment
60
Registered
2018-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients presented with breast lump.

Interventions

None listed

Sponsors

Katurba medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.To include all female patients with solid lesion of more than 1 cm (in largest dimension) on ultrasonography/mammography or both. 2.To include patients with histopathological and imaging follow up.

Exclusion criteria

Exclusion criteria: 1.To exclude patients with breast lesion less than 1 cm. 2.To exclude patients with cystic breast lesions. 3.To exclude post- operative patients/post chemotherapy. 4.To exclude patients who are not having histopathological and imaging follow up

Design outcomes

Primary

MeasureTime frame
Comparing ADC values with histopathology.Timepoint: primary outcome will be evaluated by April 2019—

Secondary

MeasureTime frame
correlating ADC values with histopathology.Timepoint: secondary outcome will be evaluated by April 2019—

Countries

India

Contacts

Public ContactKopuru harsha

Kasturba Medical College

smitis11@hotmail.com9449640418

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026